Author Question: The patient is scheduled to begin treatment with sumatriptan (Imitrex). Before initiating treat-ment ... (Read 61 times)

elizabeth18 · **on:** Jul 23, 2018

The patient is scheduled to begin treatment with sumatriptan (Imitrex). Before initiating treat-ment with the drug, the primary care provider should plan to screen the patient for evidence of which of the following conditions?

a. Coronary disease
b. Chronic obstructive pulmonary disease
c. Hypertension
d. Psychiatric disorders

Question 2

A patient who has been started on drug therapy with metaxalone (Skelaxin) for muscle spasm secondary to leg injury becomes irritable and complains of feeling nervous all the time. Select the accurate interpretation of this symptom.

a. The patient is taking extra doses of the drug for added pain relief.
b. This is a response to the drug experienced by some patients.
c. This indicates that the patient is having an allergic reaction to the drug.
d. The patient is looking for secondary gains from the injury.

ryrychapman11 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
The most life-threatening adverse effects of triptans include myocardial infarction in patients with known coronary disease.

Answer to Question 2

ANS: B
Some patients taking carisoprodol, chlorzoxazone, metaxalone, or orphenadrine experience in-creased excitability, nervousness, and irritability while taking this drug.